Veracyte (VCYT) Consolidated Net Income (2012 - 2026)

Veracyte (VCYT) has 15 years of Consolidated Net Income data on file, last reported at $28.7 million in Q1 2026.

• Quarterly Consolidated Net Income rose 306.9% year-over-year to $28.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $88.0 million (up 166.3% YoY) and the FY2025 annual result came in at $66.4 million, up 174.89% from the prior year.
• Consolidated Net Income eased to $28.7 million in Q1 2026 per VCYT's latest filing, from $41.1 million in the prior quarter.
• The five-year high for Consolidated Net Income was $41.1 million in Q4 2025, with the low at -$29.6 million in Q3 2023.
• Average Consolidated Net Income over 5 years is $488235.3, with a median of -$1.9 million recorded in 2024.
• Year-over-year, Consolidated Net Income tumbled 640.92% in 2023 and surged 704.77% in 2025.
• Veracyte's Consolidated Net Income stood at -$3.8 million in 2022, then plunged by 640.92% to -$28.3 million in 2023, then soared by 118.08% to $5.1 million in 2024, then surged by 704.77% to $41.1 million in 2025, then slumped by 30.31% to $28.7 million in 2026.
• Business Quant data shows VCYT's Consolidated Net Income at $28.7 million in Q1 2026, $41.1 million in Q4 2025, and $19.1 million in Q3 2025.